Topic

ARWR

1 article

Arrowhead’s REDEMPLO Launch: A New Commercial Era Unfolds

Investing Strategy 4 min read

Arrowhead’s REDEMPLO Launch: A New Commercial Era Unfolds

Arrowhead Pharmaceuticals (ARWR) achieved $264 million in FQ1 2026 revenue, coinciding with the pivotal REDEMPLO approval, signaling a…

Mar 14, 2026 · Marcus Klein